The GAD-7 is one of the most widely used measures of anxiety. It's only seven questions and takes just a couple of minutes to complete; why not give it a go, see how you score?

Over the last 2 weeks, how often have you been bothered by any of the following?
1. Feeling nervous, anxious or on edge?
2. Not being able to stop or control worrying?
3. Worrying too much about different things?
4. Trouble relaxing?
5. Being so restless that it is hard to sit still?
6. Becoming easily annoyed or irritable?
7. Feeling afraid as if something awful might happen?
The GAD-7


Your results are confidential. This page doesn't collect, save or transmit any personal information.

Scoring the GAD-7

Anxiety severity is calculated by assigning scores of 0, 1, 2, and 3 to the response categories of 'not at all'; 'several days'; 'more than half the days' and 'nearly every day' respectively. The total score for the seven items scored ranges from 0 to 21.

Scores of 5, 10, and 15 represent cutpoints for mild, moderate, and severe anxiety, respectively

Using the threshold score of 10, the GAD‐7 has a sensitivity of 89% and a specificity of 82% for generalised anxiety disorder. It is moderately good at screening three other common anxiety disorders - panic disorder (sensitivity 74%, specificity 81%), social anxiety disorder (sensitivity 72%, specificity 80%), and post‐traumatic stress disorder (sensitivity 66%, specificity 81%). The sum of the first two questions is sometimes used as a rapid guide to the likely presence of anxiety. The 'GAD-2' as this is called, gives a score on the range of zero to six. A score of three or more warrants further investigation.

When screening for anxiety disorders, a recommended cutpoint for further evaluation is a score of ten or more. A diagnosis cannot be made using the GAD-7 alone; a professional clinical interview should consider the possibility of physical causes, drug use and any manic / hypomanic episodes.

Copies of the PHQ and GAD-7 are available from the PHQ Screeners website. From the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD PHQ). The GAD-7 was developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues. PRIME-MD is a trademark of Pfizer Inc. Copyright 1999 Pfizer Inc. All rights reserved.

Spitzer, R.L., Kroenke, K., Williams, J.B.W., Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 166 p.1092-1097.

About Parabl

Parabl Talking Therapies is a service to meet the needs of adults aged 18 and over, resident within Anglesey, Gwynedd, Conwy, Denbighshire, Flintshire and Wrexham in Wales, UK. The service is for you if you have:

  • Common mental health difficulties, e.g. mild to moderate anxiety or depression
  • Stable severe and enduring mental health problems
  • Experienced a bereavement
  • Relationship problems
  • Common psychosexual difficulties

Visit the Parabl website or call 0300 777 2257 for more information.


This page is for information only. Nothing here is a substitute for professional advice, diagnosis or treatment.

Never disregard medical advice or delay seeking advice because of something you have read on the Internet.

Please seek the advice of a qualified health professional regarding any medical or mental health issues.